SPCC4F11.04c Antibody

Shipped with Ice Packs
In Stock

Description

Nomenclature and Identification

  • Hypothesis 1: Typographical Error
    The identifier "SPCC4F11.04c" does not conform to standard antibody naming conventions (e.g., "scFv-FcC21" , "N6" , or "nirsevimab" ). It may represent a typographical error or internal laboratory code not yet published.

  • Hypothesis 2: Undisclosed or Proprietary Compound
    The term could denote a confidential or early-stage research antibody not disclosed in public databases. For example, antibodies like 6D3 and 4A8 (targeting SARS-CoV-2) were initially described in niche contexts before broader publication .

Comparative Analysis of Similar Antibodies

While "SPCC4F11.04c" remains unidentified, the search results highlight antibodies with analogous naming structures or therapeutic roles:

Antibody NameTarget/FunctionKey FeaturesSource
scFv-FcC21CSPG4 proteoglycanFully human antibody; inhibits tumor growth by blocking ERK/FAK pathways
6D3SARS-CoV-2 S1/S2 cleavage siteBlocks TMPRSS2/furin access; binds PRRA insert
N6HIV CD4-binding siteNear-pan neutralization breadth; avoids glycan steric clashes
NirsevimabRSV F proteinReduces RSV hospitalization by 54 per 1000 infants

Recommendations for Further Investigation

  1. Verify Nomenclature: Cross-check identifiers with repositories like the Antibody Registry (https://antibodyregistry.org) or UniProt.

  2. Explore Patent Databases: Investigate pending patents for proprietary antibodies (e.g., USPTO, WIPO).

  3. Contact Authors: Reach out to researchers specializing in antibody engineering (e.g., teams behind , , or ).

Limitations of Current Data

  • No structural, functional, or clinical data for "SPCC4F11.04c" exists in PMC/PubMed Central archives ( ).

  • The identifier may reference a non-antibody protein, a synthetic construct, or a deprecated code.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPCC4F11.04c; Inositol phosphoceramide mannosyltransferase 2; IPC mannosyltransferase 2
Target Names
SPCC4F11.04c
Uniprot No.

Target Background

Function
SPCC4F11.04c Antibody is required for the synthesis of mannosyl phosphorylinositol ceramide (MIPC) in conjunction with imt1 and imt3. It catalyzes the addition of mannosyl to phosphorylinositol ceramide (IPC). MIPC is essential for various cellular functions, including cell morphology, cell-surface distribution of ergosterol, localization of plasma-membrane transporters, and lipid-raft-mediated endocytosis of plasma membrane proteins to the vacuole.
Database Links
Protein Families
Glycosyltransferase 32 family
Subcellular Location
Golgi apparatus, cis-Golgi network membrane; Multi-pass membrane protein. Golgi apparatus, trans-Golgi network membrane; Multi-pass membrane protein.

Q&A

What is SPCC4F11.04c and why is it significant in research?

SPCC4F11.04c is a gene that encodes a mannosyl transferase in Schizosaccharomyces pombe. Mannosyl transferases catalyze the transfer of mannose residues during protein glycosylation processes. In S. pombe, this enzyme is particularly significant for cell wall formation and integrity. Based on homology studies, SPCC4F11.04c appears related to proteins involved in β-1,6-glucan synthesis pathways, which are essential for fungal cell wall structure .

The protein encoded by SPCC4F11.04c likely functions in the post-Golgi vesicles or late Golgi apparatus, consistent with other glycosylation enzymes. Research into this protein provides insights into fundamental cellular processes including protein modification, cell wall biogenesis, and membrane trafficking in eukaryotic systems.

What experimental applications can SPCC4F11.04c antibodies support?

SPCC4F11.04c antibodies can support multiple research applications:

  • Western blot analysis for protein expression and modification studies

  • Immunoprecipitation for protein complex isolation

  • Immunofluorescence microscopy for subcellular localization

  • Proteomic analyses of glycosylation pathways

  • Cell wall composition studies

  • Functional characterization of protein glycosylation networks

These applications collectively enable comprehensive investigation of SPCC4F11.04c's roles in cellular processes, particularly those related to protein glycosylation and cell wall formation.

What approaches are most effective for generating specific antibodies against SPCC4F11.04c?

Generating specific antibodies against SPCC4F11.04c requires careful consideration of several factors:

ApproachAdvantagesConsiderations
Peptide immunizationTargets specific epitopes, cost-effectiveMay miss conformational epitopes
Recombinant protein immunizationRecognizes native structure, higher specificityMore complex production process
GST-fusion peptidesEnhanced immunogenicity, simplified purificationMay introduce non-specific responses
Affinity purificationIncreases specificity, reduces backgroundAdditional processing required

For SPCC4F11.04c specifically, using GST-fusion peptides has been demonstrated as an effective approach for generating polyclonal antibodies with sufficient specificity for research applications . The selection of unique, non-conserved epitopes is crucial for preventing cross-reactivity with other mannosyl transferases.

What validation methods ensure antibody specificity for SPCC4F11.04c?

Comprehensive validation should include:

  • Western blot analysis comparing wild-type and sup11-depleted strains

  • Immunoprecipitation followed by mass spectrometry confirmation

  • Peptide competition assays to verify epitope-specific binding

  • Cross-reactivity testing against related proteins

  • Validation across multiple experimental conditions and applications

Researchers should document band patterns, molecular weights, and subcellular distribution patterns to establish reliable validation criteria. For transmembrane proteins like SPCC4F11.04c, additional validation through proteinase K protection assays can verify topology predictions .

How should researchers design immunofluorescence experiments to accurately determine SPCC4F11.04c localization?

For accurate subcellular localization:

  • Cell preparation: Optimize spheroplasting procedures using enzymatic digestion (lysing enzymes) to maintain cellular integrity while ensuring antibody accessibility.

  • Fixation: Compare paraformaldehyde and methanol fixation to determine optimal epitope preservation.

  • Controls: Include both negative controls (pre-immune serum) and positive controls (co-staining with known Golgi/ER markers).

  • Membrane protein considerations: Use detergent concentrations appropriate for transmembrane proteins.

  • Signal verification: Confirm specificity through parallel experiments with GFP-tagged constructs (C-terminal or N-terminal tagging, depending on topology) .

Analysis should include co-localization studies with organelle markers, particularly those for the Golgi apparatus and post-Golgi vesicles, where glycosylation enzymes typically reside.

What methods effectively isolate native SPCC4F11.04c for functional studies?

Native SPCC4F11.04c isolation requires specialized approaches:

  • Membrane protein extraction using detergent solubilization (Triton X-100, NP-40, or digitonin)

  • Sucrose density gradient centrifugation for subcellular fractionation

  • Immunoprecipitation using validated antibodies

  • Affinity chromatography for tagged versions of the protein

  • Size exclusion chromatography to separate protein complexes

Researchers should note that membrane protein isolation often requires optimization of detergent type and concentration to maintain native conformations. For SPCC4F11.04c specifically, successful isolation has been achieved through sucrose gradient fractionation methods coupled with detergent extraction .

How can researchers study SPCC4F11.04c's role in cell wall formation and glycosylation pathways?

To investigate SPCC4F11.04c's functional role:

  • Gene depletion studies: Utilize nmt81-regulated expression systems to control protein levels

  • Cell wall component analysis: Measure β-1,6-glucan content in control vs. SPCC4F11.04c-depleted cells

  • Glycoprotein profiling: Analyze glycoprotein composition using PAS-Silver staining techniques

  • Genetic interaction studies: Test interactions with other glycosylation pathway components

  • Transcriptome analysis: Identify downstream effects on cell wall genes and glycosylation pathways

Research has shown that Sup11p (encoded by SPCC4F11.04c) significantly impacts β-1,6-glucan synthesis, with depletion resulting in complete absence of this cell wall component . This suggests a key regulatory or catalytic role in cell wall biogenesis pathways.

What approaches can distinguish between direct and indirect effects of SPCC4F11.04c dysfunction?

Distinguishing primary from secondary effects requires multiple approaches:

  • Time-course analysis: Monitor changes following conditional depletion to identify earliest effects

  • Genetic suppressor screens: Identify genes that can compensate for SPCC4F11.04c deficiency

  • Domain mutation studies: Create specific functional domain mutations to isolate functions

  • Complementation experiments: Test rescue with wild-type vs. mutant constructs

  • Comparative analysis: Contrast effects with other mannosyl transferase mutants

Research has demonstrated that SPCC4F11.04c depletion affects glycosylation pathways, septum formation, and cell wall integrity . Careful experimental design is essential to distinguish which effects represent direct consequences of protein absence versus downstream cellular responses.

How can researchers resolve non-specific binding issues when using SPCC4F11.04c antibodies?

To improve antibody specificity:

ProblemSolution StrategyImplementation Details
Multiple bands in Western blotAntibody purificationAffinity purification against GST-fusion peptides of Sup11p
High backgroundOptimization of blockingTest various blocking agents; BSA has shown better results than milk proteins
Cross-reactivityPre-absorptionPre-incubate antibody with lysates from deletion strains
Variable resultsStandardized protocolsEstablish consistent sample preparation and antibody dilution protocols

When working with membrane proteins like SPCC4F11.04c, additional considerations include optimizing detergent concentrations and ensuring complete solubilization without disrupting epitope accessibility .

What factors influence SPCC4F11.04c detection in different experimental systems?

Detection sensitivity depends on:

  • Protein expression levels: SPCC4F11.04c may be expressed at relatively low levels, requiring signal amplification methods

  • Post-translational modifications: Glycosylation status affects antibody binding and protein mobility

  • Subcellular localization: Membrane localization necessitates appropriate extraction methods

  • Protein topology: Transmembrane orientation influences epitope accessibility

  • Experimental conditions: Buffer composition, pH, and detergent selection significantly impact detection

Research has shown that SPCC4F11.04c is subject to O-mannosylation, which affects both protein stability and detection characteristics in experimental systems . Researchers should consider these modifications when interpreting experimental results.

How should researchers interpret contradictory results from different SPCC4F11.04c antibody preparations?

When facing contradictory results:

  • Epitope mapping: Determine which protein regions each antibody recognizes

  • Validation comparison: Assess the validation rigor for each antibody preparation

  • Functional domain awareness: Consider whether antibodies target catalytic or regulatory domains

  • Post-translational modification sensitivity: Test whether glycosylation affects antibody recognition

  • Application-specific optimization: Evaluate whether antibodies perform differently across applications

What statistical approaches are most appropriate for analyzing quantitative data from SPCC4F11.04c studies?

For robust statistical analysis:

  • Establish appropriate normalization controls (housekeeping proteins stable under experimental conditions)

  • Perform power analyses to determine required sample sizes

  • Apply appropriate statistical tests based on data distribution (parametric vs. non-parametric)

  • Use multiple comparison corrections when analyzing complex datasets

  • Incorporate biological replicates to account for natural variation

  • Consider bayesian approaches for integrating diverse data types

When analyzing SPCC4F11.04c expression or functional data, researchers should consider the inherent variability in membrane protein extraction and the impact of cell wall integrity on experimental consistency.

How can SPCC4F11.04c antibodies facilitate studies of protein-protein interactions in glycosylation pathways?

For protein interaction studies:

  • Co-immunoprecipitation with SPCC4F11.04c antibodies followed by mass spectrometry

  • Proximity labeling approaches (BioID, APEX) to identify proteins in close proximity

  • Blue native PAGE to preserve native protein complexes

  • Crosslinking mass spectrometry to capture transient interactions

  • Two-hybrid screening to identify direct binding partners

Research has shown that mannosyl transferases often function in multi-protein complexes within the secretory pathway. SPCC4F11.04c likely participates in such complexes during cell wall biogenesis and glycosylation processes .

What role might SPCC4F11.04c antibodies play in understanding evolutionary conservation of glycosylation machinery?

Evolutionary studies can be approached through:

  • Cross-species immunoblotting to test antibody recognition of homologous proteins

  • Comparative localization studies across fungal species

  • Functional complementation experiments with homologs from other organisms

  • Epitope conservation analysis across fungal and other eukaryotic species

  • Structural analysis of conserved domains recognized by antibodies

SPCC4F11.04c shows significant homology to Saccharomyces cerevisiae Kre9, which is involved in β-1,6-glucan synthesis, suggesting evolutionary conservation of this glycosylation function across fungal species . Antibodies recognizing conserved epitopes could provide valuable tools for comparative studies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.